Trimetazidine Hydrochloride IP 35 mg is a cardiovascular medication used to improve blood flow in the heart and manage angina pectoris (chest pain). It works by optimizing the energy metabolism of heart cells, helping the heart muscle use oxygen more efficiently, which reduces the frequency and severity of angina attacks. Trimetazidine is often prescribed as a part of long-term treatment for patients with stable angina, especially when lifestyle modifications and other medications alone are insufficient. This medication is generally well-tolerated and is suitable for adults with chronic heart conditions under medical supervision. Regular use, along with a balanced diet and exercise, may enhance heart health and overall quality of life.
